Ryan Lucas

Ryan Lucas is a journalist who covers the Justice Department for NPR. He focuses on national security issues including counterterrorism and counterintelligence. His work has taken him to various locations around the world including Poland, Egypt and Lebanon where he covered topics such as the fallout from secret CIA prisons in Eastern Europe, the ouster of Hosni Mubarak in 2011 and the turmoil that followed, the Libyan civil war, the Syrian conflict and the rise of the Islamic State. He has also reported on intelligence and national security for Congressional Quarterly. Ryan earned a bachelor's degree from The College of William and Mary, and a master's degree from Jagiellonian University in Krakow, Poland.

Biography:  https://www.npr.org/people/544275644/ryan-lucas

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

  • Ryan Lucas covers the Justice Department for NPR.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

DEA and DOJ Consider Reclassifying Marijuana: Implications for Medical Research and the Cannabis Industry

DEA and DOJ Consider Reclassifying Marijuana: Implications for Medical Research and the Cannabis Industry

Broke On: Tuesday, 30 April 2024 The DEA and DOJ propose reclassifying marijuana from a Schedule I to a Schedule III drug, recognizing its medical benefits and easing research. If approved, marijuana would join drugs like ketamine in this category. The process involves DOJ recommendation, OMB review, DEA notice, public comment period, and Congressional Review Act action. Potential benefits include industry growth and new treatments; however, state-federal conflicts persist.